We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Top Buys

Rank Stock Value
1
SDRL
Seadrill Limited Common Stock
SDRL
+$25.6M
2
VIPS icon
Vipshop
VIPS
+$16.3M
3
DBRG icon
DigitalBridge
DBRG
+$15.8M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.9M
5
ALBO
Albireo Pharma Inc
ALBO
+$5.21M

Top Sells

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$57.6M
2
BBWI icon
Bath & Body Works
BBWI
+$22.6M
3
BILI icon
Bilibili
BILI
+$13M
4
COWN
Cowen Inc. Class A Common Stock
COWN
+$12.3M
5
GILD icon
Gilead Sciences
GILD
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 39.37%
2 Financials 7.66%
3 Consumer Discretionary 5.31%
4 Communication Services 3.82%
5 Industrials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMUS icon
151
T-Mobile US
TMUS
$185B
$814K 0.05%
13,000
-14,000
-52% -$940K
VRTX icon
152
Vertex Pharmaceuticals
VRTX
$121B
$812K 0.05%
5,000
– –
LITS
153
Lite Strategy Inc
LITS
$32.8M
$801K 0.05%
+19,826
New +$1.22M
MCD icon
154
McDonald's
MCD
$192B
$799K 0.05%
4,550
+1,500
+49% +$266K
PLX icon
155
Protalix BioTherapeutics
PLX
$191M
$795K 0.05%
263,140
– –
LIN icon
156
Linde
LIN
$221B
$794K 0.05%
+5,174
New +$818K
EXPD icon
157
Expeditors International
EXPD
$22B
$791K 0.05%
+11,800
New +$829K
GE icon
158
GE Aerospace
GE
$374B
$785K 0.05%
22,536
+4,800
+27% +$217K
SCHW
159
Charles Schwab
SCHW
$183B
$780K 0.05%
19,000
– –
RYTM icon
160
Rhythm Pharmaceuticals
RYTM
$6.81B
$779K 0.05%
+29,720
New +$821K
SYRE icon
161
Spyre Therapeutics
SYRE
$8.54B
$778K 0.05%
+3,886
New +$824K
AIZ icon
162
Assurant
AIZ
$13.8B
$765K 0.05%
8,700
– –
APA icon
163
APA Corp
APA
$13.2B
$749K 0.04%
28,000
+3,000
+12% +$111K
NEM icon
164
Newmont
NEM
$98.7B
$742K 0.04%
21,200
+12,000
+130% +$389K
ASMB icon
165
Assembly Biosciences
ASMB
$498M
$737K 0.04%
+2,833
New +$820K
UAA icon
166
Under Armour
UAA
$2.84B
$716K 0.04%
+40,000
New +$821K
IFF icon
167
International Flavors & Fragrances
IFF
$20.2B
$715K 0.04%
5,400
+1,500
+38% +$208K
TLPH icon
168
Talphera
TLPH
$66.4M
$709K 0.04%
15,085
-8,867
-37% -$594K
QCOM icon
169
Qualcomm
QCOM
$155B
$690K 0.04%
12,300
– –
CTAS icon
170
Cintas
CTAS
$81.9B
$686K 0.04%
16,400
– –
A icon
171
Agilent Technologies
A
$39.1B
$675K 0.04%
10,160
– –
IBM icon
172
IBM
IBM
$211B
$673K 0.04%
6,187
+539
+10% +$64.7K
TEVA icon
173
Teva Pharmaceuticals
TEVA
$40.8B
$666K 0.04%
43,000
– –
CDTX
174
DELISTED
Cidara Therapeutics
CDTX
$659K 0.04%
15,334
– –
ORCL icon
175
Oracle
ORCL
$374B
$659K 0.04%
14,655
-24,000
-62% -$1.15M
5 6
7
8 9

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.